|
GSK3B expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.59520010720871E-10 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.7653599999945E-05 |
| Normal-vs-Stage2 |
1.207630E-02 |
| Normal-vs-Stage3 |
1.277700E-02 |
| Normal-vs-Stage4 |
5.002400E-01 |
| Stage1-vs-Stage2 |
6.522400E-01 |
| Stage1-vs-Stage3 |
8.971600E-01 |
| Stage1-vs-Stage4 |
3.591800E-01 |
| Stage2-vs-Stage3 |
7.699600E-01 |
| Stage2-vs-Stage4 |
2.426200E-01 |
| Stage3-vs-Stage4 |
3.408600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.01220000048308E-07 |
| Normal-vs-AfricanAmerican |
3.61199999999728E-05 |
| Normal-vs-Asian |
4.153800E-01 |
| Caucasian-vs-AfricanAmerican |
7.280600E-01 |
| Caucasian-vs-Asian |
4.909200E-01 |
| AfricanAmerican-vs-Asian |
3.547000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.26950000020909E-07 |
| Normal-vs-Female |
7.74739999931384E-08 |
| Male-vs-Female |
1.400060E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.612290E-02 |
| Normal-vs-Extreme_Weight |
5.696900E-03 |
| Normal-vs-Obese |
1.68409999999897E-05 |
| Normal-vs-Extreme_Obese |
1.391810E-01 |
| Normal_Weight-vs-Extreme_Weight |
6.763200E-01 |
| Normal_Weight-vs-Obese |
4.256400E-01 |
| Normal_Weight-vs-Extreme_Obese |
7.205600E-01 |
| Extreme_Weight-vs-Obese |
1.450810E-01 |
| Extreme_Weight-vs-Extreme_Obese |
5.163800E-01 |
| Obese-vs-Extreme_Obese |
9.528000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.624700E-03 |
| Normal-vs-Age(41-60Yrs) |
1.23300000209881E-08 |
| Normal-vs-Age(61-80Yrs) |
1.023550E-04 |
| Normal-vs-Age(81-100Yrs) |
1.017360E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.422400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.560000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.762600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.311700E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.962000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.325200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.16270004735242E-09 |
| Normal-VS-Type2 PRCC |
1.404290E-02 |
| Normal-VS-KIRP CIMP |
2.100000E-02 |
| Normal-VS-Unclassified PRCC |
2.159600E-03 |
| Type1 PRCC-VS-Type2 PRCC |
1.958420E-02 |
| Type1 PRCC-VS-KIRP CIMP |
9.861000E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
7.933600E-01 |
| Type2 PRCC-VS-KIRP CIMP |
2.607400E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
9.412300E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
8.825800E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.668640E-01 |
| Normal-vs-N1 |
4.438000E-03 |
| Normal-vs-N2 |
7.763400E-01 |
| N0-vs-N1 |
2.574100E-02 |
| N0-vs-N2 |
9.653000E-01 |
| N1-vs-N2 |
4.103400E-01 |
|
|
